Back to Journals » OncoTargets and Therapy » Volume 9

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer

Total article views   HTML views PDF downloads Totals
9,068 Dovepress* 7,205+ 1,430 8,635
PubMed Central* 1,863 318 2,181
Totals 9,068 1,748 10,816
*Since 8 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar